Literature DB >> 34655333

A critical evaluation of longitudinal changes of astigmatism following implantation of toric implantable collamer lens (TICL): a comparison between treated and untreated cases over 4 years.

Maja Bohac1, Alma Biscevic2, Ivan Gabric2, Kresimir Gabric2, Violeta Shijakova2, Sudi Patel2.   

Abstract

PURPOSE: To evaluate residual astigmatism following correction with toric implantable collamer lens (TICL) (group I) over a period of 4 years and compare with the change of astigmatism in spectacle wearers (group II).
METHODS: Groups I (86 cases implanted with TICL [EVO + Visian ICL, Staar Surgical, Nidau, Switzeland], preop refractive error [sphere and cylinder] - 22.25 DS to - 1.00 DS and - 5.50 DC to - 1.00 DC) and II (80 cases initial refractive error [sphere and cylinder] - 18.00 DS to 0.00 DS and - 7.00 DC to - 1.00 DC) were reviewed annually. Refractive and tomography data were subjected to vector analysis to determine surgically induced astigmatism (SIA), angle of error [Δθ° = angle of target-induced astigmatism (TIA) - angle of SIA], and ΔC [TIA-SIA powers] and total corneal astigmatism (TCA) in group I and induced change in astigmatism (ICA) in group II.
RESULTS: In group I, on all occasions, SIA correlated with TIA (p < 0.05); differences between SIA and TIA means were insignificant and changes in TCA were not correlated with ΔC. Mean (± sd, 95% CI) residual astigmatic powers (RA) in attending group I cases (1-4 years) were - 0.40 DC (0.58, - 0.52 to - 0.28), - 0.40 DC (0.59, - 0.52 to - 0.27), - 0.41 DC (0.58, - 0.54 to - 0.28), and - 0.61 DC (0.74, - 0.82 to - 0.40). In group II, the corresponding ICA powers were - 0.47 DC (0.53, - 0.61 to - 0.32), - 0.49 DC (0.48, - 0.69 to - 0.29), - 0.60 DC (0.40, - 0.76 to - 0.44), and - 0.86 DC (0.71, - 1.19 to - 0.52). Differences between RA and ICA were not significant. Of the group I cases presenting at 1-4 years postop, 23, 18, 16, and 28 had RA powers ≤  - 0.75 DC. Of these 12, 10, 6, and 16 were associated with Δθ° > 5° (ΔC - 0.50 to 0 DC) and 5, 1, 4, and 4 were related to ΔC (Δθ° < 5°).
CONCLUSION: The development of astigmatism after TICL implantation is on par with the natural change in astigmatism in untreated cases. In about 50% of TICL cases presenting with astigmatism ≤  - 0.75 DC, the residual astigmatism could be neutralized by realigning the TICL.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Astigmatism; Implantable collamer lens; Phakic intraocular lenses; Vector analysis

Mesh:

Year:  2021        PMID: 34655333     DOI: 10.1007/s00417-021-05449-w

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Axis alignment and rotational stability after implantation of the toric implantable collamer lens for myopic astigmatism.

Authors:  Ayman N Hashem; Alaa M El Danasoury; Hamed M Anwar
Journal:  J Refract Surg       Date:  2009-10       Impact factor: 3.573

2.  Collamer intraocular lens: clinical results from the US FDA core study.

Authors:  D C Brown; S L Ziémba
Journal:  J Cataract Refract Surg       Date:  2001-06       Impact factor: 3.351

3.  Toric Implantable Collamer Lens for moderate to high myopic astigmatism.

Authors:  Donald R Sanders; David Schneider; Robert Martin; David Brown; David Dulaney; John Vukich; Stephen Slade; Steven Schallhorn
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

4.  Toric implantable collamer lens for moderate to high myopic astigmatism: 3-year follow-up.

Authors:  Esin Sogutlu Sari; David P Pinero; Anil Kubaloglu; Pinar Sorgun Evcili; Arif Koytak; Isil Kutlutürk; Yusuf Ozerturk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-10       Impact factor: 3.117

5.  Outcomes and possible risk factors associated with axis alignment and rotational stability after implantation of the Toric implantable collamer lens for high myopic astigmatism.

Authors:  Xun-Lun Sheng; Wei-Ning Rong; Qin Jia; Ya-Ni Liu; Wen-Juan Zhuang; Qing Gu; Yan Sun; Bo Pan; De-Jun Zhu
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

6.  Visian toric implantable collamer lens for correction of compound myopic astigmatism.

Authors:  Daniel Elies; Tirso Alonso; Javier Puig; Oscar Gris; José Luís Güell; Andreu Coret
Journal:  J Refract Surg       Date:  2010-04-07       Impact factor: 3.573

7.  United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: three-year follow-up.

Authors:  Donald R Sanders; Kimberley Doney; Monica Poco
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

8.  Postoperative astigmatism and axis stability after implantation of the STAAR Toric Implantable Collamer Lens.

Authors:  Sung Chul Park; Young Kyo Kwun; Eui-Sang Chung; Kyeon Ahn; Tae-Young Chung
Journal:  J Refract Surg       Date:  2009-05       Impact factor: 3.573

9.  Evaluation of axis alignment and refractive results of toric phakic IOL using image-guided system.

Authors:  Sherif Emerah
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

10.  Toric Implantable Collamer Lens for high myopic astigmatic Asian eyes.

Authors:  John Chang; Silvania Lau
Journal:  Ophthalmology       Date:  2009-09-10       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.